Comprehensive Introduction to CMR T2 Mapping
Cardiovascular Magnetic Resonance (CMR) has evolved from a purely morphological imaging tool into a sophisticated platform for tissue characterization. Among its most powerful quantitative sequences is T2 Mapping. While standard "dark-blood" or "bright-blood" T2-weighted imaging provides qualitative assessment of myocardial edema, T2 Mapping offers a objective, pixel-wise quantification of the T2 relaxation time within the myocardium.
In clinical cardiology and radiology, T2 Mapping is considered the gold standard for identifying myocardial edema (swelling). Because edema is a hallmark of acute inflammation, ischemia, and various cardiomyopathies, T2 Mapping has become an indispensable tool for clinicians aiming to differentiate between acute and chronic myocardial injury.
The Physics and Mechanism of T2 Mapping
To understand T2 Mapping, one must first understand the concept of T2 relaxation. When protons in the heart tissue are exposed to an external magnetic field and a radiofrequency (RF) pulse, they align and then return to their equilibrium state. T2 relaxation, also known as transverse relaxation, refers to the decay of the transverse magnetization caused by the dephasing of proton spins.
The Technical Process
In a standard T2-weighted image, the signal intensity is influenced by several factors, including the T2 relaxation time, T1 relaxation time, and proton density. This makes qualitative assessment subjective. T2 Mapping, however, utilizes a series of images acquired with different "echo times" (TE).
| Component | Description |
|---|---|
| Pulse Sequence | Usually based on a T2-prepared bSSFP (balanced Steady-State Free Precession) or GRE sequence. |
| Data Acquisition | Multiple images are acquired with varying T2-preparation times. |
| Curve Fitting | The pixel intensity is plotted against the echo times to calculate the T2 decay curve. |
| Output | A parametric map where each pixel value represents the T2 time in milliseconds (ms). |
By generating these maps, the radiologist can measure the absolute T2 value of a specific region of interest (ROI), allowing for a high degree of diagnostic precision that is independent of the scannerโs gain settings or subjective visual interpretation.
Clinical Indications and Diagnostic Usage
CMR T2 Mapping is indicated whenever there is a clinical suspicion of myocardial inflammation or acute injury. Because T2 values are significantly prolonged in the presence of free water (edema), this technique is highly sensitive.
Primary Clinical Applications
- Acute Myocarditis: T2 Mapping is highly sensitive for detecting focal or diffuse myocardial edema, which is a diagnostic criterion for acute myocarditis (Lake Louise Criteria).
- Acute Myocardial Infarction (AMI): It is used to delineate the "area at risk" (AAR). By comparing the area of edema to the area of late gadolinium enhancement (LGE), clinicians can calculate the "myocardial salvage index."
- Takotsubo Cardiomyopathy: Helps distinguish this stress-induced condition from acute coronary syndromes by demonstrating transient, reversible myocardial edema.
- Cardiac Transplant Rejection: Used to monitor for acute cellular rejection, which often presents with interstitial edema.
- Systemic Inflammatory Diseases: Evaluation of heart involvement in sarcoidosis, lupus, or vasculitis.
Normal vs. Abnormal Interpretation
Interpreting T2 maps requires comparison against local scanner-specific reference ranges, as T2 values can vary slightly depending on the magnetic field strength (1.5T vs. 3.0T).
| Condition | T2 Value Interpretation |
|---|---|
| Normal Myocardium | Typically 40โ55 ms (at 1.5T) or 45โ60 ms (at 3.0T). |
| Acute Edema | Significantly prolonged (>60 ms at 1.5T). |
| Chronic Fibrosis | Usually normal or only mildly elevated. |
Patient Preparation and Procedure
Preparation for a CMR T2 Mapping scan is largely identical to a standard cardiac MRI.
Pre-Procedure Checklist
- Screening: Strict screening for metallic implants, pacemakers, or ICDs (unless MRI-conditional).
- Fasting: Patients are usually asked to fast for 4 hours prior to the scan, especially if contrast agents are planned.
- Heart Rate Control: Since T2 Mapping is ECG-gated, patients with irregular heart rhythms (e.g., Atrial Fibrillation) may require beta-blockers to lower the heart rate for clearer images.
The Procedure Steps
- Patient Positioning: The patient lies supine; ECG leads are placed on the chest to synchronize image acquisition with the cardiac cycle.
- Localizer Scans: Initial scout images are taken to identify cardiac anatomy.
- T2 Mapping Acquisition: The technician triggers the sequence. The patient must hold their breath for 8โ10 seconds per slice to prevent motion artifacts.
- Post-Processing: The software automatically generates the parametric maps. The radiologist draws ROIs in the myocardium to obtain the mean T2 value.
Risks, Side Effects, and Contraindications
CMR T2 Mapping is a non-invasive, non-ionizing radiation procedure. However, it is not without risks or contraindications.
Key Considerations
- Gadolinium Contrast: While T2 mapping itself does not require contrast, it is often performed as part of a comprehensive CMR protocol that includes LGE imaging, which does require contrast. Patients with severe renal impairment (eGFR < 30) must be evaluated for the risk of Nephrogenic Systemic Fibrosis (NSF).
- Claustrophobia: The MRI environment is small and loud. Sedation may be required for highly anxious patients.
- Implant Safety: Always verify the "MRI Conditional" status of any implanted devices.
- Artifacts: Metallic implants (sternal wires, valves) can cause signal voids, rendering the T2 map uninterpretable in specific segments.
Frequently Asked Questions (FAQ)
1. Does T2 Mapping require contrast dye?
No. T2 Mapping is a "native" sequence, meaning it relies on the intrinsic properties of the heart tissue. However, it is usually performed alongside LGE imaging, which does require contrast.
2. Is T2 Mapping safe for patients with pacemakers?
Many modern pacemakers are MRI-conditional. You must consult with your cardiologist and the MRI safety officer to verify the specific model and settings.
3. How long does the scan take?
The actual acquisition of T2 maps takes only a few minutes, but the entire CMR exam usually lasts between 30 and 60 minutes.
4. What is the difference between T1 and T2 Mapping?
T2 Mapping is primarily used to detect myocardial edema (water content), while T1 Mapping is used to detect fibrosis or diffuse myocardial infiltration (like amyloidosis).
5. Can T2 Mapping diagnose a heart attack?
It helps identify the "area at risk" of an acute heart attack by detecting edema, but it is typically used in conjunction with other sequences to confirm the diagnosis.
6. Are there any radiation risks?
No. CMR uses magnetic fields and radiofrequency pulses. There is zero ionizing radiation involved.
7. What if I have an irregular heartbeat?
Irregular heartbeats can cause "motion artifacts." Technicians may use beta-blockers or specialized software to compensate, but severe arrhythmia can sometimes limit the quality of the maps.
8. Will I feel anything during the scan?
You may hear loud clicking or thumping noises. You will be provided with earplugs or headphones. You might feel a slight warming sensation, which is normal.
9. How accurate is T2 Mapping?
It is highly accurate and provides objective numerical data, significantly reducing the "observer variability" found in older, qualitative imaging techniques.
10. Can I drive home after the procedure?
Yes. Unless you were given sedation for anxiety, there are no restrictions on driving or returning to normal activities immediately after the scan.
Conclusion
CMR T2 Mapping represents the cutting edge of non-invasive cardiac tissue characterization. By providing a quantitative measure of myocardial edema, it empowers clinicians to make evidence-based decisions in the management of inflammatory and acute cardiac conditions. As technology continues to advance, the integration of T2 Mapping into routine clinical practice will undoubtedly lead to earlier diagnosis, better prognostic stratification, and improved patient outcomes in the field of cardiovascular medicine.